Takeda reaches agreements with six of eight defendants in US generic Actos litigation
This article was originally published in Scrip
Executive Summary
Takeda has reached a settlement agreement with another company in US patent infringement litigation it has brought against filers of ANDAs for generic versions of its oral antidiabetic Actos (pioglitazone).